Clarivate CompuMark Darts-IP Derwent Life Sciences & Healthcare MarkMonitor Web of Science
BLOG keyboard_arrow_right FEATURED ARTICLE

The Clarivate story, going strong

Today and moving forward, we are building Clarivate into a responsible, sustainable company that supports its customers, colleagues and shareholders alike, both now and in the future. A year ago, we re-introduced ourselves to the world as Clarivate.

Julia Mair
Chief Marketing & Communications Officer and Head of Sustainability
Clarivate
Clarivate Insights
July 30, 2021

Pride at Clarivate: Our commitment to diversity, equity, inclusion and belonging
Life Sciences and Healthcare
July 29, 2021

Insurance coverage of digital therapeutics: a work in progress
Chris Lewis
Primary research manager, U.S. Access & Reimbursement
Clarivate
Life Sciences and Healthcare
July 28, 2021

Type 2 diabetes in Mainland China: Shifting treatment patterns
Karan Verma
Principal Analyst
Clarivate
Clarivate Insights
July 26, 2021

Disruption and diversity – Innovators to watch 2021
Ed White
Head of Analytics, IP Group
Clarivate
Life Sciences and Healthcare
July 22, 2021

Three key trends in regulatory approvals of new medicines
Dr. Jenny Sharpe
Senior Scientific Writer, Centre for Innovation in Regulatory Science
Clarivate
Life Sciences and Healthcare
July 22, 2021

Establishing an in-house medical equipment company: Q&A with Teresa Dail
Life Sciences and Healthcare
July 22, 2021

Home healthcare: The house call makes a comeback
Parvathy Menon
U.S. Market Access Analyst
Clarivate
Clarivate Insights
July 19, 2021

Spotlight on our Chandler Global Business Center
Life Sciences and Healthcare
July 16, 2021

12 domains of public health workforce development
Clarivate Insights
July 15, 2021

Encouraging diversity and inclusion: The Vibrant colleague resource group
Clarivate Insights
July 12, 2021

Why Clarivate is embracing a more flexible, connected workplace for the future
Kerri Nelson
Chief Strategy Officer
Clarivate
Life Sciences and Healthcare
July 9, 2021

How will COVID-19 vaccine availability affect recovery of key medtech markets, R&D, M&A and supply chains?
Zaid Al-Nassir
Principal Analyst
Clarivate
Clarivate Insights
July 8, 2021

Electric vehicles charging forward
Ed White
Head of Analytics, IP Group
Clarivate
Academic & Government
July 7, 2021

The new Web of Science is now your default interface
Nina Chang
Senior Product Manager, Web of Science
Clarivate
Intellectual Property
July 1, 2021

Demystifying the 5G standard essential patent landscape: Phase 2
Ed White
Head of Analytics, IP Group
Clarivate